Antisense oligonucleotides: local delivery enhances their therapeutic potential

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.3, 1999-03, pp. : 263-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular delivery of antisense oligonucleotides

By Lebedeva I. Benimetskaya L. Stein C.A. Vilenchik M.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 101-119

Elsevier

Access to resources Recommend Favorite

Antisense Oligonucleotides As Therapeutic Agents

By Alama A. Barbieri F. Cagnoli M. Schettini G.

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

By Henry S.P. Danis R.P.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 2, 2001-02 ,pp. : 277-291

Informa Healthcare

Access to resources Recommend Favorite

Oral delivery of siRNA and antisense oligonucleotides

By Akhtar Saghir

Journal of Drug Targeting, Vol. 17, Iss. 7, 2009-08 ,pp. : 491-495

Informa Healthcare

Access to resources Recommend Favorite

Microfluidic Assembly of Lipid Nanoparticles for Delivery of Antisense Oligonucleotides

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 9, 2014-09 ,pp. : 823-828

Bentham Science Publishers

Access to resources Recommend Favorite